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Abstract
Calcium-sensitive fluorescence microscopy and molecular biology analysis have been used to study
the effects of platelet-activating factor (PAF) on intracellular calcium [Ca2+]i and IL-6 expression in
human microglia. PAF (applied acutely at 100 nM) elicited a biphasic response in [Ca2+]i consisting
of an initial rapid increase of [Ca2+]i due to release from internal stores, followed by a sustained
influx. The latter phase of the [Ca2+]i increase was blocked by SKF96365, a non-selective store-
operated channel (SOC) inhibitor. RT-PCR analysis showed PAF treatment of microglia induced
expression of the pro-inflammatory cytokine IL-6 in a time-dependent manner which was blocked
in the presence of SKF96365. However, ELISA assay showed no production of IL-6 was elicited at
any time point (1–24 h) for microglial exposures to PAF. These findings suggest that PAF
stimulation of human microglia induces expression, but not production, of IL-6 and that SOC-
mediated [Ca2+]i influx contributes to the enhanced expression of the cytokine.
Background
Microglia are resident, immunocompetent cells in the
brain. They show functional plasticity and can be acti-
vated by a diversity of inflammatory stimuli including
ones associated with neurodegenerative diseases [9,18].
The functional responses of microglia following activa-
tion include proliferation, phagocytosis and secretion. In
the latter case microglia can secrete pro- and anti-inflam-
matory cytokines, chemokines, neurotrophic factors and
excitotoxins such as glutamate [20].
One important inflammatory agent is platelet-activating
factor (PAF), an alkyl ether phospholipid compound,
which both stimulates and is produced by microglia [13].
PAF contributes to inflammatory responses in the brain
and is reported to be upregulated in CNS pathophysiol-
ogy [2,17]. Acute application of PAF to human microglia
induces a biphasic change in levels of intracellular Ca2+
([Ca2+]i) with an initial rapid phase due to intracellular
release from endoplasmic reticulum (ER) stores and a sec-
ondary phase due to influx through store operated chan-
nels (SOC) [15,31]. Importantly, SOC has been shown to
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human [31] and rodent [29] microglia. Prolonged entry
of Ca2+ through SOC in stimulated microglia could consti-
tute a coupling signal between an activating stimulus and
cellular functional response. Indeed, the involvement of
sustained Ca2+ responses has been reported as a factor in
the production of arachidonic acid by rat microglia [23].
The pro-inflammatory cytokine IL-6 is released from acti-
vated microglia and mediates inflammatory responses in
brain. Levels of IL-6 in serum and cerebrospinal fluid have
been found to be elevated in stroke patients [8,28] and the
cytokine has also been implicated in the etiopathology of
neurodegenerative disorders such as Alzheimer's disease
(AD), Parkinson's disease (PD) and HIV encephalopathy
[3,14,25]. Interestingly, some evidence is also available
suggesting that under some conditions elevated levels of
IL-6 in brain may actually be beneficial [27].
In this study we have examined a role for SOC mediated
[Ca2+]i influx in mediating actions of the inflammatory
stimulus PAF to induce IL-6 in human microglia.
Materials and methods
Preparation of cells
The procedures for the isolation of human microglia have
been previously reported [24]. In brief, human embryonic
brain tissues were dissected into small blocks, incubated
in phosphate-buffered saline (PBS) containing 0.25%
trypsin and 40 µg/ml DNase and then dissociated into
single cells by repeated pipetting. Cells were plated in T75
flasks in a medium consisting of Dulbecco's modified
Eagle's medium (DMEM) containing 5% horse serum, 5
mg/ml glucose, 25 µg/ml gentamicin, and 2.5 µg/ml
amphotericin B. Freely floating microglia were harvested
from a medium of mixed cell cultures after 7–10 days of
growth in culture flasks and plated on aclar coverslips for
identification, on poly-L-lysine-coated glass coverslips for
calcium spectrofluorometry and plated on six-well multi-
plates for RT-PCR or ELISA. CD11b and ricinus communis
agglutinin (RCA), specific markers for microglia, were
used to confirm purity of the culture which was in excess
of 98% [24,30].
Calcium spectrofluorometry
The procedures used for measurement of intracellular
Ca2+ have been reported [6,31]. Microglia were incubated
with 1 µM fura-2/AM (acetoxymethyl ester, Molecular
Probes, Eugene, OR) plus 1 µM pluronic acid in normal
physiological saline solution (PSS) for 30 min. PSS solu-
tion contained (in mM): NaCl (126), KCl (5), MgCl2
(1.2), HEPES (10), D-glucose (10) and CaCl2 (1); pH of
7.4. All reagents were obtained from Sigma (St. Louis,
MO).
Following a 20 min wash in dye-free solution, coverslips
were placed on the stage of a Zeiss Axiovert inverted
microscope employing a ×40 quartz objective lens. Cells
were exposed to alternating wavelengths of 340/380 nm
at 6 s intervals and emission light passed through a 510
nm filter. An imaging system (Empix Imaging, Missis-
sauga, ON) was used to record fluorescence ratios using a
CCD camera (Retiga 1300i, Burnaby, BC). Fluorescence
ratios were determined and converted to values of [Ca2+]i
using published procedures [11]. All experiments were
done at room temperature (20–22°C).
Reverse transcription-PCR and ELISA assay
IL-6 expression was detected with the reverse-transcriptase
polymerase chain reaction (RT-PCR). Isolation of RNAs
was performed using TRIzol (Gibco-BRL, Gaithersburg,
MD, USA) and DNA contamination was eliminated using
DNase. cDNA synthesis was done using M-MLV reverse
transcriptase (Gibco-BRL). The sequences for the human
specific primers for IL-6 as follows: sense primer: 5'-
GTGTGAAAGCAGCAAAGAGGC-3'; antisense primer: 5'-
CTGGAGGTACTCTAGGTATAC-3'. Human-specific IL-6
signals were generated with the GeneAmp thermal cycler
and Amplitaq Gold DNA polymerase (Applied Biosys-
tems, Foster City, CA). The conditions for PCR were as fol-
lows: initial denaturation at 95°C for 6 min followed by
28 cycles of denaturation at 95°C for 45 sec, annealing at
56°C for 1 min and extension at 72°C for 1 min. A final
extension step at 72°C for 10 min was carried out. PCR
products (159 bp) were identified using 1.5% agarose gels
containing ethidium bromide and visualized under UV
light. GAPDH was used as a reaction standard and human
specific primer sequences were as follows: sense primer:
5'-CCATGTTCGTCATGGGTGTGAACCA-3'; antisense
primer: 5'-GCCAGTAGAGGCAGGGATGATGTTC-3'. The
intensities of each band were measured using NIH image
J 1.24 software (National Institutes of Health, Bethesda,
MD). Relative mRNA levels for each treatment were nor-
malized to GAPDH.
Enzyme-linked immunosorbent assays (ELISA) were per-
formed according to manufacturer instructions (R & D
systems, Minneapolis, MN). Cells were plated on multi-
well plates (≈105 cells/well) and treated with PAF (100
nM) in the absence or presence of SKF96365 (20 µM for 8
hr). The cell-free supernatants were used for analysis of IL-
6 production (kit detects IL-6 as low as 0.7 pg/ml). Values
were expressed as means ± SEM and statistical significance
(p < 0.05) was determined using one-way ANOVA and
Newman-Keuls multiple comparison post-test.Page 2 of 8
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Effects of SKF96365 on SOC-mediated [Ca2+]i influx by 
PAF
PAF-induced changes in [Ca2+]i from human microglia
have previously been reported [15,21,31]. Initial study
showed a transient increase in SOC [31] but more recent
work has shown PAF application to evoke a sustained
phase of SOC following an initial component due to
depletion of Ca2+ from intracellular stores [15,21]. The
differences in PAF responses is considered in the
Discussion.
A representative response to acute application of PAF
(applied at 100 nM) is presented in Fig 1A (n = 18 cells).
A plateau level of [Ca2+]i was sustained for a duration
exceeding 2 min after removal of PAF. Following estab-
lishment of a clearly defined plateau phase, the bath solu-
tion was replaced with Ca2+-free PSS. This procedure
caused an immediate decline in [Ca2+]i to baseline levels
(Fig 1A). Long durations of SOC-mediated influx of Ca2+
have also been documented in mouse microglial cells
[29].
The results of application of the SOC inhibitor SKF96365
(at 20 µM) to the plateau phase of a PAF response is
shown in the representative recording of Fig 1B (n = 21
cells). SOC-mediated entry of Ca2+ was reduced to base-
line values by SKF96365. Amplitude of Ca2+ influx
through SOC was measured as the difference between
baseline and plateau levels and in five independent exper-
iments (n = 107 cells) the amplitude prior to SKF96365
was 140 ± 21 nM and after SKF96365 was at baseline lev-
els. Previous work has shown SKF96365 pretreatment of
human microglia (50 µM for 5 min) abolished a transient
SOC in the cells [31].
Effects of SKF96365 on microglial expression of IL-6
We next examined effects of PAF on expression of the pro-
inflammatory cytokine IL-6 in the absence and presence
of SOC inhibition. The time-dependence of PAF stimula-
tion (100 nM) of human microglia on IL-6 are presented
in Fig 2A. The representative RT-PCR showed no constitu-
tive expression of IL-6 in unstimulated microglia (lane 1
of Fig 2A). IL-6 was maximally expressed at 1 h of expo-
sure to PAF then declined to lower levels at longer treat-
ment times (longest exposure of 6 h). A similar time-
dependence for IL-6 expression was exhibited in a total of
four experiments.
A one hour exposure of human microglia to PAF was cho-
sen for subsequent RT-PCR analysis. As shown in Fig 2B,
constitutive expression of IL-6 was absent (lane 1). PAF
treatment was effective in stimulating expression of the
cytokine (Fig 2B, lane 2). The expression of IL-6 was abol-
ished when SKF96365 was included with the PAF applica-
tion (Fig 2B, lane 3). No evident IL-6 expression was
observed for PAF application in Ca2+-free PSS (Fig 2B, lane
4). SKF96365, applied alone in PSS solution, did not
cause any increase in IL-6 (Fig 2B, lane 5).
It was of interest to compare PAF as an inducer of micro-
glial IL-6 to that of LPS (lipopolysaccharide) a potent
inflammatory stimulus of cells. The results of exposure of
human microglia to LPS (100 ng/ml for 6 h) is presented
in Fig 2B (lane 6) showing LPS stimulation caused an
intense band for IL-6. Altering the number of PCR cycles
had no apparent effect on intensity (data not shown) sug-
gesting IL-6 band saturation with LPS (Fig 2B, lane 6).
Comparison of band intensity indicated LPS was a more
effective inducer of IL-6 relative to PAF. Interestingly, a
partial inhibition of LPS-induced IL-6 mRNA was
observed when SKF96365 was applied with LPS (Fig 2B,
lane 7).
Semi-quantitative RT-PCR analysis is presented in Fig 2C
and shows PAF as an effective stimulator of IL-6 expres-
sion (n = 3). However, expression of IL-6 was considera-
bly lower with PAF as a stimulus compared with LPS (Fig
2B,C). Inclusion of SKF96365 with PAF or application of
PAF in Ca2+-free PSS eliminated expression of IL-6 (n = 3).
Although LPS was not the subject of this study, the
decrease in LPS induction of IL-6 with SKF96365 is of
interest and is discussed below.
ELISA assay for effects of PAF on microglial production of 
IL-6
We next investigated production of IL-6 from PAF-treated
human microglia using an exposure time of 8 h. No pro-
duction of IL-6 was evident in four experiments (data not
shown); levels of IL-6 were below the detection levels for
ELISA assay (≤ 1 pg/ml). In order to determine if the treat-
ment time was a limiting factor in IL-6 production, a series
of experiments using different microglial times of expo-
sure to PAF were undertaken (from 1–24 h). The results
are presented in Fig 3; no significant production of IL-6 (n
= 4) was found for any treatment time (PAF applied for
1,2,8 or 24 h).
We also examined if a ten-fold increase in PAF concentra-
tion (to 1 µM) would be effective in producing IL-6. As
shown in Fig 3, this higher concentration of PAF also had
no effect to induce IL-6 production for treatment times of
8 or 24 h (n = 3 independent experiments). The effects of
LPS stimulation were also determined in these experi-
ments (using 100 ng/ml for 8 h). Microglia, treated with
LPS, produced high concentrations of IL-6 to levels
exceeding 400 pg/ml (n = 4 independent experiments).Page 3 of 8
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PAF-induced Ca2+ responses. A: Representative trace (n = 18 cells) showing change in [Ca2+]i induced by PAF (100 nM). 
Following a prolonged level of SOC-mediated influx of Ca2+, the perfusion of Ca2+-free PSS abolished the response. B: Results 
from a separate experiment showing effects of SKF96365 (20 µM) on a PAF-induced increase in [Ca2+]i (n = 21 cells). 
SKF96365 application, during a sustained entry of Ca2+ through SOC, effectively reduced [Ca2+] to baseline levels.Page 4 of 8
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Expression of IL-6 in PAF treated human microglia. A: RT-PCR analysis for different exposure times of microglia to 
PAF (applied at 100 nM). B: Effects of PAF, PAF plus SKF96365, PAF plus Ca2+-free and SKF96365 applied alone (1 h treat-
ments). Also shown are effects of LPS and LPS plus SKF96365 (6 hr treatments). GAPDH was used as a reaction standard. C: 
Semi-quantitative RT-PCR for effects of the different treatments. * P < 0.05 compared with unstimulated control; # P < 0.05 
compared with PAF treated microglia.Page 5 of 8
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The results from this work indicate that PAF-mediated
changes in [Ca2+]i are involved in the cellular expression
of the pro-inflammatory agent, IL-6 in human microglia.
In essence, activation of SOC acts as a transcriptional con-
trol for expression of IL-6. Our results show that inhibi-
tion of SOC with SKF96365 blocked both the influx of
Ca2+ and microglial expression of IL-6. However, PAF-
induced expression of IL-6 (Fig 2) did not translate into
production of the cytokine (Fig 3). This result could sug-
gest that an additional signal or factor may be required for
microglial secretion of IL-6.
As found for other types of unexcitable cells, microglia do
not normally express voltage-dependent Ca2+ channels
[7]. The sustained entry of Ca2+ through SOC is likely an
important pathway for microglial responses to specific
inflammatory stimuli [15,22,26]. Although opening of
SOC is required for re-filling of ER stores, other roles for
this influx pathway have not been well established. Acti-
vation of SOC is necessary for expression of IL-6 but an
additional signal is required to produce the pro-inflam-
matory cytokine in human microglia. The activation state
of human microglia may influence the extent of Ca2+
influx through SOC. Microglia showing an ameboid mor-
phology are considered representative of an activated state
whereas cells with a ramified morphology are considered
quiescent. We have found sustained SOC responses from
PAF-stimulated microglia in cells demonstrating ameboid
morphology [15,21] and also in the present work. How-
ever, an initial study using a mixture of ameboid and ram-
ified shaped cells, showed a transient SOC response with
stimulation by PAF [31]. Further work will be useful to
correlate expression of SOC with cell activation.
A recent review has provided a detailed overview of ATP as
an inducer of IL-6 expression and production in MG-5
microglial cell line [12]. ATP and the purinergic agonist
BzATP were both effective in increasing expression of IL-6
with effects involving activation of the p38 MAPK path-
way. However, ATP (activator of both metabotropic P2YR
and ionotropic P2XR) but not BzATP (activator of the
ionotropic subtype P2X7R), was found to induce produc-
tion of the cytokine. The role of SOC in MG-5 cell
responses is unclear since ATP evokes a monophasic
change in [Ca2+]i due to P2YR dependent release from
intracellular stores. In human microglia we have attrib-
uted the lack of a SOC phase of [Ca2+]i due to concomi-
tant ATP binding to some P2XR (not P2X7R) causing
cellular depolarization and block of Ca2+ influx [6].
PAF induction of IL-6 was found to be time-dependent
(Fig 2A) in addition to the dependence on the presence of
extracellular Ca2+ and SOC (Fig 2B). We observed no IL-6
expression at one-half hour and a maximal level at one
hour of microglial exposure to PAF. Little or no IL-6 was
expressed with longer PAF treatments of microglia. Inhibi-
tion of endoplasmic reticulum Ca2+ ATPase (SERCA) has
been reported to increase IL-6 mRNA expression in rodent
macrophages within 15 min [4,19]. Blockade of SERCA,
by compounds such as thapsigargin, and subsequent
depletion of intracellular stores is a stimulatory protocol
for activation of SOC. However, SOC-mediated entry of
Ca2+ was not determined in the rodent studies.
Although PAF was an effective stimulator of IL-6 expres-
sion in human microglia, LPS elicited a higher expression
of the cytokine. Indeed, bands for IL-6 appeared saturated
(Fig 2B) and showed no change in intensity with
increased number of PCR cycles (data not shown). Satura-
tion with LPS would prevent a quantitative comparison
between PAF and LPS as activating stimuli for microglial
expression of IL-6 (Fig 2C). An interesting observation
was that SKF96365 partially inhibited the LPS-induced
expression of IL-6 (Fig 2C). Although LPS has been
reported to act in a Ca2+-independent manner on macro-
phages [19], several studies have found the bacterial com-
pound evokes changes in [Ca2+]i in microglia/
ELISA assays for production of IL-6 in human microgliaFigure 3
ELISA assays for production of IL-6 in human micro-
glia. PAF (at 100 nM) induced no significant production of IL-
6 from microglia following exposures from 1–24 h (n = 4 for 
each time points). PAF (at 1 µM) induced no significant pro-
duction of IL-6 (following exposures for 8 h and 24 h; n = 3 
for both time points); these values are near the lower limits 
for sensitivity of the ELISA kits. LPS was used as a positive 
control in these experiments (n = 4); note the change of 
scale for the ordinate (from 10 to 400 pg/ml). * P < 0.05 
compared with unstimulated control.Page 6 of 8
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ment of SOC in LPS induction of cytokines.
The present results may have relevance to roles of IL-6 in
aging. Several studies have provided evidence for age-
dependent increases in levels of IL-6 in rodent brain
[reviewed in [10]]. For example, one finding was that
brains from older mice showed considerable elevations in
expression and production of IL-6 compared with brains
from younger animals [33]. This result was correlated
with microglial production of the cytokine [33]. It will be
of interest to determine if PAF-stimulated adult human
microglia are more potent producers of IL-6 compared
with fetal human cells.
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